Verition Fund Management
PRCT icon

Verition Fund Management’s Procept Biorobotics PRCT Stock Holding History

Verition Fund Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-34,800
Closed -$1.09M – 3264
2025
Q4 		$1.09M Sell
34,800
-26,993
-44% -$895K ﹤0.01% 2086
2025
Q3 		$2.21M Buy
61,793
+26,815
+77% +$1.22M 0.01% 1888
2025
Q2 		$2.01M Sell
34,978
-10,656
-23% -$602K 0.01% 1933
2025
Q1 		$2.66M Sell
45,634
-9,644
-17% -$658K 0.01% 1377
2024
Q4 		$4.45M Buy
55,278
+28,668
+108% +$2.45M 0.02% 970
2024
Q3 		$2.13M Buy
+26,610
New +$1.89M 0.01% 1375
2024
Q2 		– Sell
-22,837
Closed -$1.13M – 3209
2024
Q1 		$1.13M Buy
22,837
+16,600
+266% +$790K 0.01% 1544
2023
Q4 		$261K Buy
+6,237
New +$212K ﹤0.01% 1871

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Verition Fund Management's PRCT Position: Q1 2026 in Review

Verition Fund Management sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 34,800 shares — an estimated $1.09M sold.

Verition Fund Management first reported a position in PRCT in Q4 2023 and held it in 8 quarters. The position peaked at $4.45M in Q4 2024. 257 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Verition Fund Management reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 34,800 Procept Biorobotics shares in Q1 2026, an estimated $1.09M.
  • Verition Fund Management first reported a position in Procept Biorobotics in Q4 2023 and held it in 8 quarters.
  • Verition Fund Management's Procept Biorobotics position peaked at $4.45M in Q4 2024.
  • 257 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.